Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting

Figure 2

Unadjusted life years and quality-adjusted life years (QALYs). This graph illustrates the base case results in terms of total unadjusted life years and QALYs.